Literature DB >> 25285381

Creating anatomically accurate and reproducible intracranial xenografts of human brain tumors.

Angela M Pierce1, Amy K Keating2.   

Abstract

Orthotopic tumor models are currently the best way to study the characteristics of a tumor type, with and without intervention, in the context of a live animal - particularly in sites with unique physiological and architectural qualities such as the brain. In vitro and ectopic models cannot account for features such as vasculature, blood brain barrier, metabolism, drug delivery and toxicity, and a host of other relevant factors. Orthotopic models have their limitations too, but with proper technique tumor cells of interest can be accurately engrafted into tissue that most closely mimics conditions in the human brain. By employing methods that deliver precisely measured volumes to accurately defined locations at a consistent rate and pressure, mouse models of human brain tumors with predictable growth rates can be reproducibly created and are suitable for reliable analysis of various interventions. The protocol described here focuses on the technical details of designing and preparing for an intracranial injection, performing the surgery, and ensuring successful and reproducible tumor growth and provides starting points for a variety of conditions that can be customized for a range of different brain tumor models.

Entities:  

Mesh:

Year:  2014        PMID: 25285381      PMCID: PMC4694722          DOI: 10.3791/52017

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  A novel method of intracranial injection via the postglenoid foramen for brain tumor mouse models.

Authors:  Kenichiro Iwami; Hiroyuki Momota; Atsushi Natsume; Sayano Kinjo; Tetsuya Nagatani; Toshihiko Wakabayashi
Journal:  J Neurosurg       Date:  2011-12-09       Impact factor: 5.115

2.  A method to accurately inject tumor cells into the caudate/putamen nuclei of the mouse brain.

Authors:  Shinya Yamada; Vazgen Khankaldyyan; Xiang Bu; Atsushi Suzuki; Ignacio Gonzalez-Gomez; Kouichi Takahashi; J Gordon McComb; Walter E Laug
Journal:  Tokai J Exp Clin Med       Date:  2004-12

3.  Primary orthotopic glioma xenografts recapitulate infiltrative growth and isocitrate dehydrogenase I mutation.

Authors:  J Geraldo Valadez; Anuraag Sarangi; Christopher J Lundberg; Michael K Cooper
Journal:  J Vis Exp       Date:  2014-01-14       Impact factor: 1.355

4.  Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme.

Authors:  Brian C Baumann; Jay F Dorsey; Joseph L Benci; Daniel Y Joh; Gary D Kao
Journal:  J Vis Exp       Date:  2012-09-25       Impact factor: 1.355

Review 5.  Non-germline genetically engineered mouse models for translational cancer research.

Authors:  Joerg Heyer; Lawrence N Kwong; Scott W Lowe; Lynda Chin
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

6.  Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Authors:  Caterina Giannini; Jann N Sarkaria; Atsushi Saito; Joon H Uhm; Evanthia Galanis; Brett L Carlson; Mark A Schroeder; C David James
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

7.  Reproducible and efficient murine CNS gene delivery using a microprocessor-controlled injector.

Authors:  A I Brooks; M W Halterman; C A Chadwick; B L Davidson; M Haak-Frendscho; C Radel; C Porter; H J Federoff
Journal:  J Neurosci Methods       Date:  1998-04-30       Impact factor: 2.390

8.  Establishing intracranial brain tumor xenografts with subsequent analysis of tumor growth and response to therapy using bioluminescence imaging.

Authors:  Tomoko Ozawa; C David James
Journal:  J Vis Exp       Date:  2010-07-13       Impact factor: 1.355

9.  Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.

Authors:  Uma T Shankavaram; Markus Bredel; William E Burgan; Donna Carter; Philip Tofilon; Kevin Camphausen
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

10.  Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.

Authors:  Nikisha Carty; Kevin R Nash; Milene Brownlow; Dana Cruite; Donna Wilcock; Maj-Linda B Selenica; Daniel C Lee; Marcia N Gordon; Dave Morgan
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more
  4 in total

1.  Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform.

Authors:  Cheng-Chia Wu; Kunal R Chaudhary; Yong Hum Na; David Welch; Paul J Black; Adam M Sonabend; Peter Canoll; Yvonne M Saenger; Tony J C Wang; Cheng-Shie Wuu; Tom K Hei; Simon K Cheng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-19       Impact factor: 7.038

2.  VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.

Authors:  Tasleem Arif; Yakov Krelin; Itay Nakdimon; Daniel Benharroch; Avijit Paul; Daniela Dadon-Klein; Varda Shoshan-Barmatz
Journal:  Neuro Oncol       Date:  2017-07-01       Impact factor: 12.300

3.  Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.

Authors:  Anna Shteinfer-Kuzmine; Tasleem Arif; Yakov Krelin; Shambhoo Sharan Tripathi; Avijit Paul; Varda Shoshan-Barmatz
Journal:  Oncotarget       Date:  2017-05-09

4.  Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging.

Authors:  Jennifer A Geisler; Jonathan M Spehar; Sarah A Steck; Anna Bratasz; Reena Shakya; Kimerly Powell; Gina M Sizemore
Journal:  J Vis Exp       Date:  2020-06-07       Impact factor: 1.355

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.